TRAIN 2

Human lung cancer tissue under the microscope. The helper macrophages (in red) are surrounded by enzymes (in yellow) that activate the stimulating part of the antibodies they develop. This targeted action prevents damage to healthy tissue.

Neutralize the defense, go on the offensive: Smart antibodies to fight cancer

Researchers from the Weizmann Institute of Science have identified immunosuppressive macrophages in tumors and developed smart molecules called MiTEs that target the TREM2 receptor and locally activate IL-2 – with the aim of overcoming resistance to immunotherapy without causing side effects.
Science website logo
SEARCH